Herbalife Ltd. (NYSE:HLF) Receives $9.90 Consensus Price Target from Brokerages
by Kim Johansen · The Markets DailyHerbalife Ltd. (NYSE:HLF – Get Free Report) has been given an average recommendation of “Hold” by the five analysts that are covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, two have given a hold rating and two have assigned a buy rating to the company. The average 12-month price target among analysts that have covered the stock in the last year is $9.90.
HLF has been the topic of a number of analyst reports. B. Riley decreased their target price on shares of Herbalife from $17.00 to $12.00 and set a “buy” rating on the stock in a report on Thursday, October 31st. Citigroup dropped their price objective on Herbalife from $16.00 to $13.00 and set a “buy” rating for the company in a research note on Friday, October 25th. Mizuho upped their target price on Herbalife from $8.00 to $9.00 and gave the stock a “neutral” rating in a research note on Friday, November 1st. StockNews.com upgraded Herbalife from a “hold” rating to a “buy” rating in a research report on Monday, November 4th. Finally, DA Davidson decreased their price objective on shares of Herbalife from $13.00 to $7.50 and set a “neutral” rating on the stock in a research report on Thursday, October 31st.
View Our Latest Stock Analysis on Herbalife
Hedge Funds Weigh In On Herbalife
Several institutional investors have recently modified their holdings of HLF. Bank of New York Mellon Corp boosted its stake in Herbalife by 8.2% in the second quarter. Bank of New York Mellon Corp now owns 410,827 shares of the company’s stock worth $4,268,000 after buying an additional 31,137 shares in the last quarter. Van ECK Associates Corp grew its holdings in shares of Herbalife by 10.3% during the 2nd quarter. Van ECK Associates Corp now owns 8,684 shares of the company’s stock valued at $90,000 after purchasing an additional 808 shares during the last quarter. nVerses Capital LLC raised its position in Herbalife by 240.0% in the 2nd quarter. nVerses Capital LLC now owns 5,100 shares of the company’s stock worth $53,000 after purchasing an additional 3,600 shares during the period. Rhumbline Advisers raised its position in Herbalife by 1.3% in the 2nd quarter. Rhumbline Advisers now owns 149,057 shares of the company’s stock worth $1,549,000 after purchasing an additional 1,953 shares during the period. Finally, LSV Asset Management lifted its stake in Herbalife by 47.0% in the second quarter. LSV Asset Management now owns 1,556,902 shares of the company’s stock worth $16,176,000 after purchasing an additional 497,919 shares during the last quarter.
Herbalife Stock Performance
Shares of NYSE HLF opened at $6.77 on Tuesday. Herbalife has a fifty-two week low of $6.21 and a fifty-two week high of $13.70. The stock has a market cap of $682.36 million, a PE ratio of 7.96, a price-to-earnings-growth ratio of 0.26 and a beta of 1.18. The stock has a fifty day moving average of $7.56 and a 200-day moving average of $8.38.
Herbalife (NYSE:HLF – Get Free Report) last posted its earnings results on Wednesday, October 30th. The company reported $0.57 earnings per share for the quarter, beating analysts’ consensus estimates of $0.19 by $0.38. Herbalife had a negative return on equity of 18.66% and a net margin of 1.73%. The business had revenue of $1.24 billion during the quarter, compared to analyst estimates of $1.23 billion. On average, sell-side analysts predict that Herbalife will post 1.51 EPS for the current year.
Herbalife Company Profile
Herbalife Ltd. provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers products in the areas of weight management; targeted nutrition; energy, sports, and fitness; outer nutrition; and literature and promotional items.
Featured Articles
- Five stocks we like better than Herbalife
- Stock Splits, Do They Really Impact Investors?
- Build-Your-Bowl Battle: CAVA, Chipotle, and Sweetgreen Face Off
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Insiders Are Loading Up: 3 Key Stock Picks for Investors
- Compound Interest and Why It Matters When Investing
- How Cigna Remains at the Top of the Health Insurance Food Chain